Hengyi Chen

1.6k total citations · 1 hit paper
53 papers, 1.2k citations indexed

About

Hengyi Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Hengyi Chen has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Hengyi Chen's work include Electrocatalysts for Energy Conversion (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Hengyi Chen is often cited by papers focused on Electrocatalysts for Energy Conversion (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Hengyi Chen collaborates with scholars based in China, Taiwan and United States. Hengyi Chen's co-authors include Yong He, Yubo Wang, Rui Han, Li Li, Caiyu Lin, Kunlin Li, Fenfen Sun, Conghua Lu, Rui‐Ting Gao and Lei Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hengyi Chen

50 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ruthenium And Silver Synergetic Regulation NiFe LDH Boosting Long‐Duration Industrial Seawater Electrolysis

2024 84 citations Hengyi Chen, Rui‐Ting Gao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hengyi Chen China	18	466	319	288	252	160	53	1.2k
Liuling Xiao United States	15	483 1.0×	271 0.8×	365 1.3×	216 0.9×	391 2.4×	25	1.6k
Yun Liu China	21	419 0.9×	151 0.5×	91 0.3×	165 0.7×	92 0.6×	85	1.3k
Hai Hu China	20	351 0.8×	259 0.8×	79 0.3×	232 0.9×	90 0.6×	48	1.1k
Meiqi Xu China	16	637 1.4×	151 0.5×	537 1.9×	265 1.1×	107 0.7×	29	1.9k
Ruifen Wang China	20	216 0.5×	215 0.7×	118 0.4×	236 0.9×	109 0.7×	76	1.1k
Shengyu Zhou China	20	268 0.6×	422 1.3×	203 0.7×	56 0.2×	522 3.3×	129	1.8k
Yunfei Xia China	21	418 0.9×	141 0.4×	60 0.2×	205 0.8×	326 2.0×	62	1.3k
Jia-Yin Lin Taiwan	21	396 0.8×	304 1.0×	277 1.0×	90 0.4×	49 0.3×	61	1.2k
Yiming Xu China	16	277 0.6×	95 0.3×	84 0.3×	172 0.7×	124 0.8×	46	870
Jiansong Huang China	19	501 1.1×	169 0.5×	100 0.3×	850 3.4×	749 4.7×	59	2.0k

Countries citing papers authored by Hengyi Chen

Since Specialization

Citations

This map shows the geographic impact of Hengyi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengyi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengyi Chen more than expected).

Fields of papers citing papers by Hengyi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengyi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengyi Chen. The network helps show where Hengyi Chen may publish in the future.

Co-authorship network of co-authors of Hengyi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hengyi Chen. A scholar is included among the top collaborators of Hengyi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengyi Chen. Hengyi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Hengyi, et al.. (2025). Unbiased Stable Photoelectrochemical Glycerol Oxidation on Hematite Photoanodes. Angewandte Chemie International Edition. 64(38). e202509062–e202509062.

Chen, Hengyi, et al.. (2025). Re and Ru Co‐Doped Transition Metal Alloy as a Bifunctional Catalyst for Electrooxidation of Glycerol to Formate Coupled with H ₂ Production. Angewandte Chemie International Edition. 64(20). e202501766–e202501766. 16 indexed citations

Chen, Hengyi, et al.. (2025). High‐Selectivity Electrocatalytic Oxidation of Glycerol to C ₃ ‐Glyceraldehyde Coupled to H ₂ O ₂ Production. Angewandte Chemie. 137(48).

Zhou, Chaoyang, et al.. (2024). Mitigating interfacial stresses in strip-bonded beams by appending end-anchored unbonded segments. Engineering Structures. 306. 117864–117864. 1 indexed citations

Wang, Xiaoyang, Hengyi Chen, Baocang Liu, et al.. (2023). Constructing heterostructure of WP/WP2 to enhance catalytic activity and stability toward hydrogen generation. Journal of Power Sources. 585. 233659–233659. 3 indexed citations

Liu, Zhigang, Mengli Wu, Jingjing Ma, et al.. (2023). Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis. International Journal of Nanomedicine. Volume 18. 3125–3139. 4 indexed citations

Chen, Hengyi, Minghao Hu, Xiaoyang Wang, et al.. (2023). Constructing Novel Ternary Heterostructure of CeP₅O₁₄/WP/WS₂ to Enhance Catalytic Activity for Hydrogen Evolution in a Full pH Range. SHILAP Revista de lepidopterología. 4(9). 18 indexed citations

Liu, Haixia, Xiaohui Chen, Yimin Jia, et al.. (2023). Facing inevitable PARPis resistance: Mechanisms and therapeutic strategies for breast cancer treatment. SHILAP Revista de lepidopterología. 1(2). 15 indexed citations

Hu, Minghao, Hengyi Chen, Baocang Liu, et al.. (2022). Coupling ceria with dual-phased molybdenum carbides for efficient and stable hydrogen evolution electrocatalysis at large-current-density in freshwater and seawater. Applied Catalysis B: Environmental. 317. 121774–121774. 46 indexed citations

10.

Chen, Hengyi, Conghua Lu, Caiyu Lin, et al.. (2021). VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis. 42(6). 880–890. 9 indexed citations

11.

Wang, Yubo, Rui Han, Qiushi Wang, et al.. (2021). Biological Significance of 18F-FDG PET/CT Maximum Standard Uptake Value for Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer Patients. International Journal of General Medicine. Volume 14. 347–356. 8 indexed citations

12.

Lin, Caiyu, Hengyi Chen, Rui Han, et al.. (2021). Hexokinases II‐mediated glycolysis governs susceptibility to crizotinib in ALK‐positive non‐small cell lung cancer. Thoracic Cancer. 12(23). 3184–3193. 16 indexed citations

13.

Chen, Hengyi, Caiyu Lin, Tao Peng, et al.. (2020). Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1. Cell Death and Disease. 11(2). 111–111. 20 indexed citations

14.

Wang, Yubo, Caiyu Lin, Rui Han, et al.. (2020). Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways. 3 Biotech. 10(6). 287–287. 12 indexed citations

15.

Chen, Hengyi, Rongbing Jin, Yubo Wang, et al.. (2018). The Utility of ¹⁸F-FDG PET/CT for Monitoring Response and Predicting Prognosis after Glucocorticoids Therapy for Sarcoidosis. BioMed Research International. 2018. 1–6. 14 indexed citations

16.

Lin, Caiyu, Conghua Lu, Li Li, et al.. (2018). Metformin synergistically enhances the antitumor activity of the third‐generation EGFR‐TKI CO‐1686 in lung cancer cells through suppressing NF‐κB signaling. The Clinical Respiratory Journal. 12(12). 2642–2652. 11 indexed citations

17.

Jiao, Lin, Caiyu Lin, Conghua Lu, et al.. (2018). Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway. Biologics. Volume 12. 75–86. 30 indexed citations

18.

Wang, Yubo, Rui Han, Zhaojun Chen, et al.. (2016). A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database. Oncology Reports. 35(4). 2257–2269. 12 indexed citations

19.

Li, Li, Peng Zhang, Jun Kang, et al.. (2016). A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non–Small-cell Lung Cancer. Clinical Lung Cancer. 18(3). 340–343. 18 indexed citations

20.

Li, Li, Rui Han, Hualiang Xiao, et al.. (2014). Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal. Clinical Cancer Research. 20(10). 2714–2726. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact